What are the contents of the Periodic Safety Update Report?

 

The requirements for the periodic safety update report are defined in Article 86 of the EU MDR 2017/745. Specifically, the PSUR should include:

 

  • the conclusion of the risk-benefit analysis
  • the main results of the post-marketing clinical follow-up
  • Sales volume of the device and other characteristics of the population using it and, where possible, frequency of use of the device.

 

The PSUR must be prepared for each medical device or category of medical device and must include the results and conclusions of the post-market surveillance analyzes data collected as a result of the post-market surveillance plan together with a justification and description of any preventive actions and corrective measures undertaken.

 

Benefit-risk analysis

 

The benefit-risk analysis is part of the risk management process and must be performed throughout the life cycle of the medical device. The assessment of the risks and benefits of the device should be an ongoing process in which post-market supervisory information must be used. 

 

Indeed, a different benefit-risk balance may emerge as supervisory data reveal additional safety information. The risk assessment of the device should be performed using post-market data.

 

Depending on the type of device involved, the following factors need to be considered during the risk assessment process:

 

  • The number of cases (numerator) and the accuracy of the estimate, taking into account the source of the data;
  • The amount and/or duration of use (denominator) expressed as the number of devices, patients, patient time, etc. And accuracy of the estimate;
  • The frequency (calculated from the numerator and denominator) of a specific event;
  • The impact on the individual patient (effects on symptoms, quality or quantity of life, reversibility);
  • The impact on public health;
  • Risks related to a specific population;
  • Any patient risk factors (e.g. age, relevant co-morbidities, disease severity)
  • The strength of the evidence and its uncertainties, including the analysis of the conflicting evidence, if applicable.

 

The main results of the post-marketing clinical follow-up

 

All completed and ongoing PMCF studies worldwide should be provided. The following information must be provided:

 

  • Name or code of the study
  • Name of the countries of study
  • Number of study sites
  • Number of patients enrolled and target number
  • Number of serious accidents or deaths

 

Sales volume of the device

Based on the EU MDR, the PSUR will include an estimate of the number of devices sold. Devices should be grouped by basic UDI-DI level (or reference code level)

 

The number of devices supplied should be based on world sales volumes and should be split according to sales volume in the EEA + CH + TR and worldwide.

 

Depending on the type of product, the number of products placed on the market can be reported using one of the following issues:

 

  • Total number of devices placed on the market or put into service
  • Number of implanted devices
  • Number of units distributed in a defined period
  • Devices on the market, based on: Devices placed on the market or put into service
  • Number of patient diagnostic tests or patient samples performed
  • Number of usage episodes (for reusable devices)
  • Active installed base
  • Other (describe)

 

Also, if post-market use of the device has occurred in special populations, other information regarding the device's distribution numbers should be provided. Populations to consider could include:

 

  • elderly population
  • pediatric population
  • pregnant or lactating women
  • patients with hepatic and/or renal insufficiency;
  • patients with disease severity other than that studied in clinical trials
  • off label use

 

Comments

Post a Comment

Popular posts from this blog

EC REP: European Authorized Representative.

Image
Due to the increasingly common presence of imported medical devices in the European Union, the figure of the Authorized Representative (EC REP, European Authorized Representative) is becoming more common. This figure must guarantee compliance with current regulations on medical devices for medical devices manufactured outside the European Union.  Regulation 2017/745 of medical devices establishes the obligation for all manufacturers of medical devices established outside the European Union to have a permanent authorized representative who serves as an interlocutor for the European health authorities and has a documentary file with technical information. of medical devices (Technical file among others). The authorized representative must be a natural or legal person based in an EU member state and appear on the labels of Medical Device CE Marking for sale in the EU.  The appointment of this EC REP must be in writing along with its acceptance and in the case of class I products, this ap
Read more

Navigating Regulatory Compliance: The Crucial Role of Medical Device Regulatory Consulting Services

Image
In the fast-paced and dynamic landscape of the healthcare industry, ensuring the safety, efficacy, and compliance of medical devices is paramount. Manufacturers face a myriad of regulatory challenges that require a deep understanding of complex frameworks. This is where  Medical Device Regulatory Consultants  Services play a pivotal role, guiding businesses through the intricate maze of regulations to ensure their products meet the highest standards.     Understanding the Regulatory Landscape: Before delving into the specifics of Medical Device Regulatory Consulting Services, it's crucial to comprehend the regulatory landscape governing medical devices. Regulatory bodies, such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe, set stringent guidelines to guarantee the quality and safety of medical devices. Navigating these regulations demands expertise, and that's precisely where consulting services become indispens
Read more

Understanding FDA Registration and Certification for Food Facilities

Image
In today's globalized world, the food industry is under constant scrutiny to ensure the safety and quality of products distributed to consumers. For companies involved in the production, distribution, or packaging of food products, compliance with regulatory standards is not just a legal obligation but also a business imperative. One of the most critical regulatory authorities in this regard is the U.S. Food and Drug Administration (FDA), which governs food safety standards and practices in the United States. This article will provide an in-depth guide on FDA Registration , FDA Certificate , and FDA Food Facility Registration , essential requirements for businesses looking to operate within the U.S. food market. What is FDA Registration? FDA Registration is the process by which food facilities must register with the U.S. Food and Drug Administration. This is mandatory for all domestic and foreign companies that manufacture, process, pack, or store food intended for consumption in
Read more